Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences.
Anne Neisig(QIMR Berghofer Medical Research Institute), Jacques Neefjes(Leiden University Medical Center), W. Martin Kast(University of Southern California), Alice J.A.M. Sijts(Leiden University), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), Mariet C.W. Feltkamp(Leiden University Medical Center), J Roelse(Leiden University), Ferry Ossendorp(Leiden University Medical Center)
Cited by 155
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549